Table 3. Additional effects for Fig 3.
| Variable | Effect on HbA1C (%), i.e. applies to Panel A | P-value | Effect on SBP (mmHg), i.e. applies to Panel B | P-value |
|---|---|---|---|---|
| BMI: low | -0.07 | < 0.005* | -2.3 | < 0.001* |
| BMI: high | +0.09 | +3.1 | ||
| Sex: female | +0.04 | 0.69 | +2.0 | 0.11 |
| SES: middle | -0.08 | 0.77 | -2.4 | 0.15 |
| SES: high | -0.06 | +0.1 | ||
| Age: low | +0.09 | 0.09 | -5.0 | < 0.001* |
| Age: high | -0.07 | +4.0 | ||
| Mental disease | -0.30 | 0.01* | -3.5 | 0.02* |
| Cardiovascular disease | -0.10 | 0.37 | N.A. | |
| Malignancy | -0.07 | 0.73 | -4.1 | 0.10 |
| COPD | 0.18 | 0.30 | -0.3 | 0.08 |
| Musculoskeletal disease | N.A. | -0.2 | 0.84 |
*P-values < 0.05. N.A., not applicable.